| |
| |
|
| Insider
Information: |
Stenhouse Mark |
| Relationship: |
Director |
| City: |
Madison |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
38,571 |
|
|
Indirect Shares
|
355 |
|
|
| Direct
Value |
$1,740,253 |
|
|
|
Indirect Value
|
$20,892 |
|
|
| Total
Shares |
38,926 |
|
|
| Total
Value |
$1,761,145 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 26.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
President, Cologuard |
2020-04-03 |
29,571 |
2020-04-03 |
355 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Chief Operating Officer |
2023-06-16 |
0 |
2023-06-16 |
0 |
Premium* |
|
|
Phathom Pharmaceuticals, Inc. |
PHAT |
Director |
2023-05-25 |
9,000 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
• – – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(14,000) |
0 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
• – – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,754) |
0 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
• – – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
14,000 |
14,000 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
• – – |
2023-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,000) |
12,708 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,811 |
26,442 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Chief Operating Officer |
• – – |
2021-03-16 |
4 |
B |
$19.00 |
$266,000 |
D/D |
14,000 |
14,000 |
2.74 |
% |
|
| EXAS |
Exact Sciences Corp |
President, Cologuard |
• – – |
2020-04-03 |
4 |
AS |
$56.69 |
$677,332 |
D/D |
(11,948) |
29,571 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President, Cologuard |
• – – |
2020-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
41,519 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President, Cologuard |
• – – |
2020-02-27 |
4 |
AS |
$80.27 |
$84,364 |
D/D |
(1,051) |
16,519 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President, Cologuard |
• – – |
2020-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,262 |
17,570 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President, Cologuard |
• – – |
2019-04-03 |
4 |
AS |
$92.54 |
$1,035,696 |
D/D |
(11,192) |
14,308 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President, Cologuard |
• – – |
2019-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,500 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
